BIHS commits ₹2,500 crore to Nivara healthcare network
Bajaj Group-backed BIHS will spend about ₹2,500 crore building Nivara across Pune and more than 10 cities, betting that most care can happen outside a hospital.
The short answer
Bajaj Integrated Health System (BIHS) will invest about ₹2,500 crore to build Nivara, an integrated network of medical centres, ambulatory surgery centres and hospitals, starting in Pune. The 15-year plan targets more than 10 cities and puts the Bajaj Group into organised outpatient care, diagnostics, pharmacy and homecare.
Key takeaways
- BIHS, backed by the Bajaj Group, will invest around ₹2,500 crore initially in its Nivara healthcare network, starting in Pune.
- Nivara will run medical centres, ambulatory surgery centres and later hospitals, integrating consultations, diagnostics, pharmacy, physiotherapy and homecare.
- A 500-bed greenfield hospital in Pune is expected over two to three years, while clinics and surgery centres will operate from leased premises.
- BIHS chief executive Nirav Bajaj said in an interview that the company believes about 70% of healthcare can be delivered outside a hospital.
- The rollout targets more than 10 cities over 15 years, which could put Nivara in competition with pharmacy chains, diagnostic labs and retail clinic formats.
Bajaj Integrated Health System (BIHS), the healthcare arm backed by the Bajaj Group, will put roughly ₹2,500 crore into building Nivara, an integrated network of clinics, day-surgery centres and hospitals. The network opens first in Pune, with a medical centre due next week, and is planned to reach more than 10 cities over about 15 years.
BIHS describes Nivara as primary-care first, with diagnostics, pharmacy, physiotherapy and homecare bundled into the same network, and hospital beds added later.
What exactly is BIHS building under the Nivara brand?
Three formats, launched in stages. Medical Centres will handle consultations, diagnostics and pharmacy. Ambulatory Centres, a term for day-care facilities where patients are treated or operated on without an overnight stay, will take orthopaedics, gastroenterology, ENT and ophthalmology cases, along with chemotherapy and dialysis. Hospitals come after that, starting with a 500-bed greenfield project in Pune expected over the next two to three years.
The medical and surgery centres will run out of leased premises. The hospital is being built from scratch. That split matters: leasing keeps early capital light and lets the company test locations before committing to land and construction, while the hospital anchors the network's reputation and referral flow.
BIHS chief executive Nirav Bajaj, son of Bajaj Auto chairman Niraj Bajaj, said that over the last two years the team visited about 35 global health institutions, from inpatient wards down to back-end services, before settling on the model.
Why does Bajaj think 70% of care can sit outside a hospital?
That is the operating thesis. Bajaj said in an interview that the company believes about 70% of healthcare can be handled outside a hospital setting, and that treating patients closer to home improves both health and quality of life. As media reports put it, a lot of healthcare does not need a hospital.
India's outpatient market is already mostly outside hospitals. What is missing is coordination. A patient sees a physician at one clinic, gets a scan at a standalone imaging centre, buys medicines at a nearby chemist and rarely has all three talking to each other. BIHS's chief enterprise and governance officer, Devina Kartha, said patient journeys are fragmented across providers and facilities with limited coordination, and that Nivara will run on shared clinical standards, governance frameworks and a connected technology stack.
We believe 70% of healthcare can be dealt with outside of the hospital.
The economics follow from that. A clinic visit, a pathology test and a physiotherapy session have thinner margins per transaction than a surgery, but they repeat far more often and cost far less to deliver than an inpatient bed. A network that keeps the patient inside its own ecosystem for tests, medicines and follow-ups captures more of the annual spend than one that only sees them when they are ill enough to be admitted.
What does this mean for pharmacy, diagnostics and retail health players?
A great deal. Nivara is walking into the same catchment as pharmacy chains, diagnostic labs and the clinic arms that several large retail and ecommerce groups have been assembling.
- Pharmacy chains: a prescription written inside a Nivara medical centre can be filled at its own counter before the patient reaches the exit. In practice, this could divert footfall from the neighbourhood chemist.
- Diagnostic labs: consultations bundled with blood tests and imaging could squeeze the standalone lab's walk-in business, though labs with hospital tie-ups may keep the high-end work.
- Retail health formats: chains that built small clinics and pharmacy corners inside stores now face a competitor with a hospital at the back of the network and a group brand founded in 1926 at the front.
- Homecare firms: nursing and physiotherapy at home is explicitly part of Nivara's plan, which could put it in competition with specialist homecare operators.
None of these players lose overnight. A single Pune medical centre and a hospital that is still years away do not reshape a market. But the Bajaj name is likely to buy trust quickly, particularly with families who treat a conglomerate's clinic as safer than an unbranded one, and that is the scarce asset in Indian primary care.
Who else is writing large cheques for Indian healthcare?
Conglomerates are moving in. The Adani Group has been building not-for-profit medical campuses and hospitals in Mumbai and Ahmedabad, backed by a ₹60,000 crore philanthropic pledge, according to media reports. That is a different structure, charity-funded and campus-scale, against BIHS's for-profit, leased-clinic rollout. Both signal the same thing: large Indian business houses see organised healthcare as a long-duration bet worth patient capital.
The metric that will matter is unit economics per centre, not headline capital. A ₹2,500 crore commitment spread over 15 years and 10-plus cities is modest per site. The real test is whether a leased medical centre reaches break-even on consultations, tests and pharmacy sales before the hospital opens and starts absorbing capital.
What should operators and investors watch next?
Three things. First, the Pune medical centre's opening and how quickly it stacks services, because a clinic that only offers consultations is a different business from one that owns the pharmacy and lab counter. Second, the 500-bed hospital's construction timeline, since delays there stretch the period the clinics must fund themselves. Third, city selection beyond Pune. Bajaj has said the aim is at least six cities in a decade, while the company's stated plan, reported in the media, targets more than 10 cities over 15 years, so the pace of new leases will show how fast the group is willing to spend.
The Bajaj Group was founded in 1926 and built its reputation in autos, financial services, electricals and consumer goods. In the interview, Nirav Bajaj spoke of bringing the same strong ethics, transparency and trust into healthcare. That is a brand promise, not a business model. The model will be judged in Pune, one clinic at a time.
Frequently asked questions
What is Nivara by BIHS?
Nivara is an integrated healthcare network being built by Bajaj Integrated Health System, backed by the Bajaj Group. It combines medical centres, ambulatory surgery centres and hospitals, and bundles consultations, diagnostics, pharmacy, physiotherapy and homecare into one connected system.
How much is BIHS investing in Nivara?
BIHS will invest around ₹2,500 crore initially, according to the company. The money goes into a Pune-first rollout of medical centres and surgery centres on leased premises, plus a 500-bed greenfield hospital expected over the next two to three years.
Which cities will Nivara open in?
Pune is the first city, with a medical centre opening next week. The company's stated plan, reported in the media, targets more than 10 cities over 15 years. Nirav Bajaj has said the aim is at least six cities within a decade.
How does Nivara compete with pharmacy and diagnostic chains?
In practice, keeping prescriptions, tests and medicines inside its own network could divert footfall from standalone chemists and diagnostic labs. It also offers physiotherapy and homecare, which could put it in competition with specialist homecare operators for the same patients.
Who leads BIHS?
Nirav Bajaj is managing director and chief executive of BIHS. He is the son of Niraj Bajaj, chairman of Bajaj Auto. Devina Kartha is chief enterprise and governance officer.
Based on company announcements, filings and reporting by The Hindu and Mint.
